MBL77 - AN OVERVIEW

mutations specified the fact that, as defined beneath, CLL therapy relies about the existence or absence of those mutations. The present consensus is, other than clonal mutations, subclonal mutations having a variant allelic frequency starting from five to 10% (and thus below the edge of detection by regular molecular tactics) may be reported, Whil